Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Clinical trial NCT03318770 · UNKNOWN

Trial details

NCT number: NCT03318770
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: UNKNOWN
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia

Start date: 2019-05-10
Primary completion: 2024-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.